Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-12

Clinical Trial Update: Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating metformin showing improved clinical pregnancy rate in women with polycystic ovarian syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Assiut University | Conditions: Reproductive Endocrinology, Polycystic Ovarian Syndrome | Phase 2 | Status: COMPLETED